Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT03702725 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma

Interventions

DRUG: Ibrutinib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]